Canntab Therapeutics Limited
CTABF
$0.00
$0.000.00%
OTC PK
| 02/28/2023 | 11/30/2022 | 08/31/2022 | 05/31/2022 | 02/28/2022 | |
|---|---|---|---|---|---|
| Net Income | -2.57M | -2.59M | -2.80M | -2.92M | -3.65M |
| Total Depreciation and Amortization | 451.40K | 469.40K | 437.40K | 504.00K | 529.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 6.50K |
| Total Other Non-Cash Items | 949.20K | 555.40K | 617.30K | 306.30K | 795.90K |
| Change in Net Operating Assets | 76.80K | -93.90K | -382.00K | -142.30K | -125.30K |
| Cash from Operations | -1.09M | -1.66M | -2.13M | -2.26M | -2.44M |
| Capital Expenditure | 0.00 | 300.00 | -900.00 | -24.10K | -118.80K |
| Sale of Property, Plant, and Equipment | 0.00 | 188.40K | 188.40K | 188.40K | 188.40K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -21.70K | -36.10K | -26.10K | -46.10K | -42.30K |
| Cash from Investing | -21.70K | 152.60K | 161.40K | 118.20K | 27.30K |
| Total Debt Issued | 0.00 | 1.30M | 1.30M | 1.30M | 1.38M |
| Total Debt Repaid | -54.70K | -73.20K | -68.50K | -63.90K | -59.40K |
| Issuance of Common Stock | 0.00 | 427.10K | 434.60K | 658.90K | 1.76M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -42.00K | 1.30M | 1.31M | 1.49M | 2.45M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.16M | -207.50K | -657.00K | -643.60K | 39.30K |